login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
THERATECHNOLOGIES INC (THTX) Stock News
NASDAQ:THTX -
CA88338H7040
-
Common Stock
3.27
USD
-0.01 (-0.3%)
Last: 9/9/2025, 4:10:04 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
THTX Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies annonce la disponibilité d’EGRIFTA WR (MC) (tésamoréline) pour injection pour la réduction de l’excès de graisse abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie
4 days ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
4 days ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
7 days ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies annonce que les agences de conseil en vote indépendantes ISS et Glass Lewis recommandent aux actionnaires de voter « EN FAVEUR » du plan d’arrangement prévu avec Future Pak
2 months ago - By: Benzinga
- Mentions:
BSET
PCYO
AZZ
MEI
...
Earnings Scheduled For July 9, 2025
2 months ago - By: Benzinga
A Look at Theratechnologies's Upcoming Earnings Report
7 days ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
7 days ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
21 days ago - By: Brodsky & Smith LLC
- Mentions:
TGNA
NWE
DSBX
NXST
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: TEGNA Inc. (NYSE - TGNA), NorthWestern Energy Group, Inc. (Nasdaq - NWE), Theratechnologies Inc. (Nasdaq - THTX), Dogwood State Bank (OTC - DSBX)
22 days ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies annonce le dépôt des documents relatifs à l’assemblée extraordinaire et l’obtention d’une ordonnance provisoire concernant son acquisition par CB Biotechnology, un membre du même groupe que Future Pak
22 days ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
22 days ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
2 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies présente ses résultats financiers pour le deuxième trimestre de 2025
2 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Reports Financial Results for the Second Quarter 2025
2 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Reports Financial Results for the Second Quarter 2025
2 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies annoncera ses résultats financiers du deuxième trimestre de l’exercice financier de 2025
2 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies to Announce Second Quarter 2025 Financial Results
2 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies to Announce Second Quarter 2025 Financial Results
2 months ago - By: Brodsky & Smith LLC
- Mentions:
OLO
GNTY
MRC
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Olo Inc. (NYSE - OLO), Theratechnologies Inc. (Nasdaq - THTX), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC)
2 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies conclut un accord définitif en vue de son acquisition par CB Biotechnology, un membre du même groupe que Future Pak
2 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
2 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
3 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Reports on its Annual Meeting of Shareholders
3 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies rend compte de son assemblée annuelle des actionnaires
3 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Reports on its Annual Meeting of Shareholders
4 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies présente à la conférence ACTHIV 2025 de nouvelles données soulignant l’importance de prendre en charge l’excès de graisse viscérale abdominale chez les personnes vivant avec le VIH
4 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
4 months ago - By: Theratechnologies
- Mentions:
TH.CA
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
Please enable JavaScript to continue using this application.